Stay updated on Vobramitamab Dose Levels in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Vobramitamab Dose Levels in Prostate Cancer Clinical Trial page.

Latest updates to the Vobramitamab Dose Levels in Prostate Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check25 days agoChange DetectedA site-wide NIH notice announces a transition from using the term “Artificial Intelligence” to “Super Intelligence” across NIH content.SummaryDifference0.5%

- Check32 days agoChange DetectedThe site’s footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check39 days agoChange DetectedThe footer now identifies the site as revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check60 days agoChange DetectedA new Revision: v3.7.0 entry was added to the study record history, indicating a recent system update. The entry for Revision: v3.6.6 was removed from the history.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, indicating a new release of the page rather than a change to study content.SummaryDifference0.1%

Stay in the know with updates to Vobramitamab Dose Levels in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vobramitamab Dose Levels in Prostate Cancer Clinical Trial page.